* National Health Investors Inc NHI.N NHI is expected
to show
a rise in quarterly revenue when it reports results on February
21.
* The Murfreesboro Tennessee-based company is expected to
report
a 10.4% increase in revenue to $76.916 million from $69.67
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for National Health
Investors
Inc is for earnings of 83 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for National
Health
Investors Inc is $58, below its last closing price of $58.58.
This summary was machine generated February 17 at 14:13 GMT.
All figures in US dollars unless otherwise stated